Lessons Learned From Five Years of Newborn Screening for Severe Combined Immunodeficiency in Israel

Atar Lev1,2, Idan Sharir1, Amos J. Simon1,3, Shiran Levy1, Yu Nee Lee1, Shirly Frizinsky1, Suha Daas4, Talia Saraf-Levy4, Arnon Broides5,6, Amit Nahum5,6,7, Suhair Hanna6,8, Polina Stepensky6,9, Ori Toker6,10, Ilan Dalal6,11, Amos Etzioni6,8, Jerry Stein12, Etai Adam13, Ayal Hendel2, Nufar Marcus6,14, Shlomo Almashanu4
1Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
2Mina and Everard Goodman Faculty of Life Sciences, Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat-Gan, Israel
3Hemato-Immunology Unit, Hematology Lab, Sheba Medical Center, Tel HaShomer, Israel
4National Newborn Screening Program, Ministry of Health, Tel-HaShomer, Israel
5Pediatric Immunology, Soroka University Medical Center, Beer-Sheva, Israel
6Jeffrey Modell Foundation Israeli Network for Primary Immunodeficiency, New York, NY
7Primary Immunodeficiency Research Laboratory, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
8Ruth Children Hospital, Rappaport Faculty of Medicine, Technion, Haifa, Israel
9Department of Bone Marrow Transplantation, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
10Faculty of Medicine, Hebrew University of Jerusalem, Israel; Allergy and Immunology Unit, Shaare Zedek Medical Center, Jerusalem, Israel
11Department of Pediatrics, Pediatric Allergy Unit, E. Wolfson Medical Center, Holon, Israel, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
12Department for Hemato-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
13Division of Pediatric Hematology and Oncology, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat-Gan, Israel
14Allergy and Immunology Unit, Schneider Children's Medical Center of Israel, Felsenstein Medical Research Center, Kipper Institute of Immunology, Petach Tikva, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

Tài liệu tham khảo

Fischer, 2015, Severe combined immunodeficiencies and related disorders, Nat Rev Dis Primers, 1, 15061, 10.1038/nrdp.2015.61 Michniacki, 2019, Severe combined immunodeficiency: a review for neonatal clinicians, Neoreviews, 20, e326, 10.1542/neo.20-6-e326 Tangye, 2020, Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee, J Clin Immunol, 40, 24, 10.1007/s10875-019-00737-x Bousfiha, 2018, The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies, J Clin Immunol, 38, 129, 10.1007/s10875-017-0465-8 Buckley, 2011, Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes, Immunol Res, 49, 25, 10.1007/s12026-010-8191-9 Buckley, 2004, Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution, Annu Rev Immunol, 22, 625, 10.1146/annurev.immunol.22.012703.104614 Brown, 2011, Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening, Blood, 117, 3243, 10.1182/blood-2010-08-300384 Chan, 2011, Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey, Clin Immunol, 138, 3, 10.1016/j.clim.2010.09.010 Heimall, 2017, Long term outcomes of severe combined immunodeficiency: therapy implications, Expert Rev Clin Immunol, 13, 1029, 10.1080/1744666X.2017.1381558 Railey, 2009, Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis, J Pediatr, 155, 834, 10.1016/j.jpeds.2009.07.049 Chan, 2011, A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID), Mol Genet Metab, 104, 383, 10.1016/j.ymgme.2011.07.007 Verbsky, 2012, The Wisconsin approach to newborn screening for severe combined immunodeficiency, J Allergy Clin Immunol, 129, 622, 10.1016/j.jaci.2011.12.004 Kwan, 2014, Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States, JAMA, 312, 729, 10.1001/jama.2014.9132 Hale, 2021, Ten years of newborn screening for severe combined immunodeficiency (SCID) in Massachusetts, J Allergy Clin Immunol Pract, 9, 2060, 10.1016/j.jaip.2021.02.006 Currier, 2021, SCID newborn screening: what we've learned, J Allergy Clin Immunol, 147, 417, 10.1016/j.jaci.2020.10.020 Gizewska, 2020, Newborn screening for SCID and other severe primary immunodeficiency in the Polish-German transborder area: experience from the first 14 months of collaboration, Front Immunol, 11, 1948, 10.3389/fimmu.2020.01948 Strand, 2020, Second-tier next generation sequencing integrated in nationwide newborn screening provides rapid molecular diagnostics of severe combined immunodeficiency, Front Immunol, 11, 1417, 10.3389/fimmu.2020.01417 Baekvad-Hansen, 2021, Implementation of SCID screening in Denmark, Int J Neonatal Screen, 7, 54, 10.3390/ijns7030054 Gongrich, 2021, First year of TREC-based national SCID screening in Sweden, Int J Neonatal Screen, 7, 59, 10.3390/ijns7030059 Truck, 2020, Swiss newborn screening for severe T and B cell deficiency with a combined TREC/KREC assay - management recommendations, Swiss Med Wkly, 150, w20254, 10.4414/smw.2020.20254 de Felipe, 2016, Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville, Pediatr Allergy Immunol, 27, 70, 10.1111/pai.12501 Argudo-Ramirez, 2019, First universal newborn screening program for severe combined immunodeficiency in Europe. Two-years' experience in Catalonia (Spain), Front Immunol, 10, 2406, 10.3389/fimmu.2019.02406 Chien, 2015, Incidence of severe combined immunodeficiency through newborn screening in a Chinese population, J Formos Med Assoc, 114, 12, 10.1016/j.jfma.2012.10.020 Mandola, 2019, Ataxia telangiectasia diagnosed on newborn screening-case cohort of 5 years' experience, Front Immunol, 10, 2940, 10.3389/fimmu.2019.02940 Audrain, 2018, Newborn screening for severe combined immunodeficiency: analytic and clinical performance of the T cell receptor excision circle assay in France (DEPISTREC Study), J Clin Immunol, 38, 778, 10.1007/s10875-018-0550-7 Gans, 2020, Retrospective analysis of a New York newborn screen severe combined immunodeficiency referral center, J Clin Immunol, 40, 456, 10.1007/s10875-020-00757-y van der Spek, 2015, TREC based newborn screening for severe combined immunodeficiency disease: a systematic review, J Clin Immunol, 35, 416, 10.1007/s10875-015-0152-6 Amatuni, 2019, Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California, 2010-2017, Pediatrics, 143, 10.1542/peds.2018-2300 Rechavi, 2017, First year of Israeli newborn screening for severe combined immunodeficiency-clinical achievements and insights, Front Immunol, 8, 1448, 10.3389/fimmu.2017.01448 Al-Mousa, 2018, High incidence of severe combined immunodeficiency disease in Saudi Arabia detected through combined T cell receptor excision circle and next generation sequencing of newborn dried blood spots, Front Immunol, 9, 782, 10.3389/fimmu.2018.00782 Knight, 2020, Follow-up for an abnormal newborn screen for severe combined immunodeficiencies (NBS SCID): a Clinical Immunology Society (CIS) survey of current practices, Int J Neonatal Screen, 6, 52, 10.3390/ijns6030052 Fronkova, 2014, The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome, PLoS One, 9, e114514, 10.1371/journal.pone.0114514 Patrawala, 2019, Nonsevere combined immunodeficiency T-cell lymphopenia identified through newborn screening, Curr Opin Allergy Clin Immunol, 19, 586, 10.1097/ACI.0000000000000586 Ward, 2013, Challenges of newborn severe combined immunodeficiency screening among premature infants, Pediatrics, 131, e1298, 10.1542/peds.2012-1921 Somech, 2013, Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study, Isr Med Assoc J, 15, 404 Somech, 2014, A call to include severe combined immunodeficiency in newborn screening program, Rambam Maimonides Med J, 5, 10.5041/RMMJ.10135 Shearer, 2014, Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience, J Allergy Clin Immunol, 133, 1092, 10.1016/j.jaci.2013.09.044 Lev, 2021, Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects, J Exp Med, 218, 10.1084/jem.20201062 Amariglio, 2010, Molecular assessment of thymus capabilities in the evaluation of T-cell immunodeficiency, Pediatr Res, 67, 211, 10.1203/PDR.0b013e3181c6e554 Cuperus, 2017, Congenital erythroderma should be considered as an urgent warning sign of immunodeficiency: a case of Omenn syndrome, Eur J Dermatol, 27, 313, 10.1684/ejd.2017.2992 Lev, 2019, Reduced function and diversity of T cell repertoire and distinct clinical course in patients with IL7RA mutation, Front Immunol, 10, 1672, 10.3389/fimmu.2019.01672 Puck, 2019, Newborn screening for severe combined immunodeficiency and T-cell lymphopenia, Immunol Rev, 287, 241, 10.1111/imr.12729 Somech, 2011, T-cell receptor excision circles in primary immunodeficiencies and other T-cell immune disorders, Curr Opin Allergy Clin Immunol, 11, 517, 10.1097/ACI.0b013e32834c233a Lev, 2013, Thymic function in MHC class II-deficient patients, J Allergy Clin Immunol, 131, 831, 10.1016/j.jaci.2012.10.040 Marcus, 2018, MHC II deficient infant identified by newborn screening program for SCID, Immunol Res, 66, 537, 10.1007/s12026-018-9019-2 Sarrabay, 2020, PSMB10, the last immunoproteasome gene missing for PRAAS, J Allergy Clin Immunol, 145, 1015, 10.1016/j.jaci.2019.11.024 Albin-Leeds, 2017, Idiopathic T cell lymphopenia identified in New York State Newborn Screening, Clin Immunol, 183, 36, 10.1016/j.clim.2017.07.002 Wahlstrom, 2015, Hematopoietic stem cell transplantation for severe combined immunodeficiency, Curr Pediatr Rep, 3, 1, 10.1007/s40124-014-0071-7 Janda, 2010, Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly, Blood, 116, 2229, 10.1182/blood-2010-03-275966 Davies, 2017, Thymus transplantation for complete DiGeorge syndrome: European experience, J Allergy Clin Immunol, 140, 1660, 10.1016/j.jaci.2017.03.020 Heimall, 2017, Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study, Blood, 130, 2718, 10.1182/blood-2017-05-781849